Cargando…
Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker
The most common cause of heart failure in the canine population is myxomatous mitral valve disease, sometimes complicated by chronic kidney disease. Many studies have been done on the use of symmetric dimethylarginine as biomarker of renal impairment in dogs affected by chronic kidney disease, few s...
Autores principales: | Savarese, Alice, Probo, Monica, Locatelli, Chiara, Zanzani, Sergio Aurelio, Gazzonis, Alessia Libera, Papa, Melissa, Brambilla, Paola Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of Veterinary Medicine, University of Tripoli and Libyan Authority for Research, Science and Technology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140385/ https://www.ncbi.nlm.nih.gov/pubmed/30237979 http://dx.doi.org/10.4314/ovj.v8i3.11 |
Ejemplares similares
-
Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity
por: Valente, Carlotta, et al.
Publicado: (2020) -
Plasmatic Dimethylarginines in Dogs With Myxomatous Mitral Valve Disease
por: Valente, Carlotta, et al.
Publicado: (2021) -
Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease
por: Galizzi, Alberto, et al.
Publicado: (2021) -
A Genomic Study of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels
por: Bionda, Arianna, et al.
Publicado: (2020) -
Pro-Inflammatory and Immunological Profile of Dogs with Myxomatous Mitral Valve Disease
por: Piantedosi, Diego, et al.
Publicado: (2022)